TOPICS No. 40

First Page		Document Content
Date: 2009-05-07 02:23:52 Multiple myeloma Thalidomide Angiogenesis Lenalidomide Plasma cell leukemia Medicine Immunosuppressants Hematologic neoplasms		TOPICS No. 40 Add to Reading List Source URL: www.med.miyazaki-u.ac.jp Download Document from Source Website File Size: 200,52 KB Share Document on Facebook

	Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma DocID: 1vahs - View Document
	Inhibition of E-Selectin or E-selectin together with CXCR4 Re-sensitizes Multiple Myeloma to Treatment Barbara Muz 1, Ph.D. Henna Bazai1, Anita Sekula1, William Fogler2 , Ted Smith2, John Magnani2 and Abdel Kareem Azab1 DocID: 1urrz - View Document
	Treatment Options for Relapsed or Refractory Multiple Myeloma: Effectiveness, Value, and Value-Based Price Benchmarks Final Evidence Report and Meeting Summary June 9, 2016 DocID: 1sh1A - View Document
	A LOOK AT TREATMENTS MAY 2016 For Multiple Myeloma Do these new drugs meet an important need? DocID: 1scZ0 - View Document
	decadron dose epidural steroid injection decadron for wisdom teeth removal decadron 1 mg injection decadron arthritis. multiple myeloma decadron kytril and decadron compatibility iv oncology decadron DocID: 1roTt - View Document